Literature DB >> 17030755

Hypoperfusion in frontotemporal dementia and Alzheimer disease by arterial spin labeling MRI.

A T Du1, G H Jahng, S Hayasaka, J H Kramer, H J Rosen, M L Gorno-Tempini, K P Rankin, B L Miller, M W Weiner, N Schuff.   

Abstract

OBJECTIVES: To test if arterial spin labeling (ASL) MRI could detect a pattern of hypoperfusion in frontotemporal dementia (FTD) vs cognitively normal (CN) control subjects; to determine the regional difference of perfusion between FTD and Alzheimer disease (AD); and to determine whether hypoperfusion in FTD correlates with cognitive impairment.
METHODS: We included 21 patients with FTD, 24 patients with AD, and 25 CN subjects in this cross-sectional MRI study. All subjects had MRI scans including T1-weighted structural images and ASL-MR images.
RESULTS: ASL-MRI detected a pattern of hypoperfusion in right frontal regions in patients with FTD vs CN subjects, similar to PET and SPECT. FTD had higher perfusion than AD in the parietal regions and posterior cingulate. Frontal hypoperfusion in FTD correlated with deficits in judgment and problem solving. Adding frontal perfusion to gray matter (GM) atrophy significantly improved the classification of FTD from normal aging to 74%, and adding parietal perfusion to GM atrophy significantly improved the classification of FTD from AD to 75%. Combining frontal and parietal lobe perfusion further improved the classification of FTD from AD to 87%.
CONCLUSION: Frontotemporal dementia and Alzheimer disease display different spatial distributions of hypoperfusion on arterial spin labeling MRI. With further development and evaluation, arterial spin labeling MRI could contribute to the differential diagnosis between frontotemporal dementia and Alzheimer disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17030755      PMCID: PMC1779761          DOI: 10.1212/01.wnl.0000238163.71349.78

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  40 in total

1.  What's in a name: voxel-based morphometric analyses of MRI and naming difficulty in Alzheimer's disease, frontotemporal dementia and corticobasal degeneration.

Authors:  Murray Grossman; Corey McMillan; Peachie Moore; Lijun Ding; Guila Glosser; Melissa Work; James Gee
Journal:  Brain       Date:  2004-02-04       Impact factor: 13.501

2.  Lateralization on neuroimaging does not differentiate frontotemporal lobar degeneration from Alzheimer's disease.

Authors:  Anne M Lipton; Raul Benavides; Linda S Hynan; Frederick J Bonte; Thomas S Harris; Charles L White; Eileen H Bigio
Journal:  Dement Geriatr Cogn Disord       Date:  2004       Impact factor: 2.959

3.  Whole-brain 3D perfusion MRI at 3.0 T using CASL with a separate labeling coil.

Authors:  S Lalith Talagala; Frank Q Ye; Patrick J Ledden; Scott Chesnick
Journal:  Magn Reson Med       Date:  2004-07       Impact factor: 4.668

4.  Region-specific decline of cerebral glucose metabolism in patients with frontotemporal dementia: a prospective 18F-FDG-PET study.

Authors:  T Grimmer; J Diehl; A Drzezga; H Förstl; A Kurz
Journal:  Dement Geriatr Cogn Disord       Date:  2004-04-06       Impact factor: 2.959

5.  Patterns of brain atrophy in frontotemporal dementia and semantic dementia.

Authors:  H J Rosen; M L Gorno-Tempini; W P Goldman; R J Perry; N Schuff; M Weiner; R Feiwell; J H Kramer; B L Miller
Journal:  Neurology       Date:  2002-01-22       Impact factor: 9.910

6.  SPECT as a diagnostic test in the investigation of dementia.

Authors:  Wanda Lojkowska; Danuta Ryglewicz; Tomasz Jedrzejczak; Halina Sienkiewicz-Jarosz; Slawomira Minc; Teresa Jakubowska; Izabela Kozlowicz-Gudzinska
Journal:  J Neurol Sci       Date:  2002-11-15       Impact factor: 3.181

7.  Diagnostic patterns of regional atrophy on MRI and regional cerebral blood flow change on SPECT in young onset patients with Alzheimer's disease, frontotemporal dementia and vascular dementia.

Authors:  A R Varma; W Adams; J J Lloyd; K J Carson; J S Snowden; H J Testa; A Jackson; D Neary
Journal:  Acta Neurol Scand       Date:  2002-04       Impact factor: 3.209

8.  Improved perfusion-weighted MRI by a novel double inversion with proximal labeling of both tagged and control acquisitions.

Authors:  Geon-Ho Jahng; Xiao-Ping Zhu; Gerald B Matson; Michael W Weiner; Norbert Schuff
Journal:  Magn Reson Med       Date:  2003-02       Impact factor: 4.668

9.  Cerebral metabolic patterns at early stages of frontotemporal dementia and semantic dementia. A PET study.

Authors:  J Diehl; T Grimmer; A Drzezga; M Riemenschneider; H Förstl; A Kurz
Journal:  Neurobiol Aging       Date:  2004-09       Impact factor: 4.673

10.  Alzheimer's disease and frontotemporal dementia exhibit distinct atrophy-behavior correlates: a computer-assisted imaging study.

Authors:  James Gee; Lijun Ding; Zhiyong Xie; Michael Lin; Christian DeVita; Murray Grossman
Journal:  Acad Radiol       Date:  2003-12       Impact factor: 3.173

View more
  113 in total

1.  Hemodynamic studies of intracranial dural arteriovenous fistulas using arterial spin-labeling MR imaging.

Authors:  T Noguchi; H Irie; Y Takase; M Kawashima; T Ootsuka; M Nishihara; Y Egashira; J Nojiri; T Matsushima; S Kudo
Journal:  Interv Neuroradiol       Date:  2010-12-17       Impact factor: 1.610

2.  Arterial spin labeling in neuroimaging.

Authors:  Sasitorn Petcharunpaisan; Joana Ramalho; Mauricio Castillo
Journal:  World J Radiol       Date:  2010-10-28

3.  Arterial spin labeling at 3.0 Tesla in subacute ischemia: comparison to dynamic susceptibility perfusion.

Authors:  S Huck; H U Kerl; M Al-Zghloul; C Groden; I Nölte
Journal:  Clin Neuroradiol       Date:  2012-01-20       Impact factor: 3.649

4.  Multivariate and univariate analysis of continuous arterial spin labeling perfusion MRI in Alzheimer's disease.

Authors:  Iris Asllani; Christian Habeck; Nikolaos Scarmeas; Ajna Borogovac; Truman R Brown; Yaakov Stern
Journal:  J Cereb Blood Flow Metab       Date:  2007-10-24       Impact factor: 6.200

Review 5.  Clinical neuroimaging using arterial spin-labeled perfusion magnetic resonance imaging.

Authors:  Ronald L Wolf; John A Detre
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

6.  Patterns of structural complexity in Alzheimer's disease and frontotemporal dementia.

Authors:  Karl Young; An-Tao Du; Joel Kramer; Howard Rosen; Bruce Miller; Michael Weiner; Norbert Schuff
Journal:  Hum Brain Mapp       Date:  2009-05       Impact factor: 5.038

7.  Arterial spin labeling MRI: an emerging biomarker for Alzheimer's disease and other neurodegenerative conditions.

Authors:  David A Wolk; John A Detre
Journal:  Curr Opin Neurol       Date:  2012-08       Impact factor: 5.710

8.  Structural Correlation-based Outlier Rejection (SCORE) algorithm for arterial spin labeling time series.

Authors:  Sudipto Dolui; Ze Wang; Russell T Shinohara; David A Wolk; John A Detre
Journal:  J Magn Reson Imaging       Date:  2016-08-29       Impact factor: 4.813

Review 9.  Emerging biomarkers in cognition.

Authors:  Meredith Wicklund; Ronald C Petersen
Journal:  Clin Geriatr Med       Date:  2013-11       Impact factor: 3.076

10.  An integrated multimodality MR brain imaging study: gray matter tissue loss mediates the association between cerebral hypoperfusion and Alzheimer's disease.

Authors:  Duygu Tosun; Norbert Schuff; Michael Weiner
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.